The UK has another new Prime Minister, Andy Burnham, who has wasted no time in laying out his plans to fundamentally reform the country’s creaking healthcare infrastructure.
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the BBC, The i Paper, Private Eye, and a swathe of other national and local publications.
UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate common issues with their medication with professional guidance.
On 6 January 2026, the National Police Chiefs’ Council (NPCC) approved the first official guidance on medical cannabis for officers in England and Wales, news that UK patients have been waiting since 2018 to receive.
The UK’s health service is fighting to keep its head above water, yet with a record-breaking winter flu pandemic sweeping the nation, and a looming industrial action set to see thousands of resident doctors walk out later this week, the water level is rising rapidly.
Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well behind its peers in one key area, data.
UK clinic Releaf expands into Germany, leveraging its digital health ecosystem to capture market share in Europe’s fast-growing medical cannabis sector.
Releaf, a leading UK medical cannabis clinic, has announced the launch of a new global expansion strategy as it prepares to take its proven healthcare model to new international markets.
